H51.22

Clinical Causes: Multiple sclerosis, particularly in young adults Brainstem strokes or hemorrhages Tumors affecting the brainstem areas involved in eye movement control Trauma or head injury leading to nerve damage Inflammatory conditions affecting the nervous system Other neurological conditions that damage the medial longitudinal fasciculus, the nerve pathway involved in INO

Key Symptoms: Difficulty moving the affected eye outward when looking to the side Nystagmus, or involuntary rapid eye movements, in the affected eye Double vision, especially when focusing on objects to the side of the affected eye Difficulty coordinating eye movements during reading or tracking moving objects Potential weakness in eye movement, causing limited gaze in the affected direction

Diagnosis Path: Diagnosis typically involves a comprehensive eye examination and neurological assessment. Eye movement tests can reveal the characteristic signs of internuclear ophthalmoplegia, such as impaired adduction (movement toward the nose) of the affected eye and abnormal nystagmus in the contralateral eye during lateral gaze. Neurological imaging studies like MRI scans are often used to identify underlying brain lesions, especially in the brainstem. Additional tests may include blood work and cerebrospinal fluid analysis if an inflammatory or infectious cause is suspected.

Treatment Protocols: Treatment of internuclear ophthalmoplegia depends on the underlying cause. Managing the primary neurological condition, such as multiple sclerosis or stroke, is central to treatment. Specific strategies might include medications to reduce inflammation or prevent further neurological damage, physical therapy, or eye exercises. Sometimes, prism glasses are used to help alleviate double vision. Regular monitoring and follow-up with healthcare professionals are vital to assess progression and response to therapy.